Archived listing. This role was posted over 30 days ago and is no longer accepting applications. We keep it for reference, but the employer may have already filled it. See today's verified listings.

Executive Assistant, Pulmovant

Pulmovant United States

See live roles like this Save · sign in Alert me to jobs like this

This one is closed

Live roles like this one

See every "Executive Assistant Pulmovant" role →

Or follow the daily Telegram channel for the best new remote roles every morning.

Posted 12 Oct 2026
Last seen 12 Oct 2026
Location United States
Lifecycle fresh
Grade D
This listing scored 54/100, which is a D. It lost the most ground on pay transparency. See the breakdown

Every figure above is arithmetic over the posting itself — its salary field, its text, its age, its tags and how many sources carry it. How the grades work →

Human Resources Senior Full Time

Pulmovant is a Roivant-backed clinical-stage biotechnology company committed to transforming the lives of patients with pulmonary diseases. Pulmovant’s first investigational candidate, mosliciguat, is designed to provide a novel, once-daily, inhaled treatment option for patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD). Mosliciguat is a potential first-in-class soluble guanylate cyclase activator with a differentiated mechanism of action currently being evaluated in the Phase 3 PHrontier global clinical trial in PH-ILD, but with potential broad applicability across the PH and ILD disease landscape. 

Pulmovant recently announced positive results from its Phase 2 PHocus study evaluating mosliciguat for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD), a progressive and life-threatening condition with significant unmet medical needs for patients. PHocus met both primary and secondary endpoints including the highest ever reported pulmonary vascular resistance (PVR) reduction in any randomized controlled PH trial. The robust results, in conjunction with mosliciguat’s once-daily, inhaled administration and potential first-in-class sGC activator profile, strongly position it as a potential single agent treatment and combination therapy for patients with PH-ILD.  These data represent a significant advancement in a devastating disease that affects ~200,000 patients with no or very limited treatment options. A Phase 3 trial is currently underway. More details can be found in the press release here.

As part of the Roivant family of companies, Pulmovant leverages the power of collaboration and innovation to drive progress.

For more information, please visit .

About Roivant:

Roivant (Nasdaq: ROIV) is a commercial-stage biopharmaceutical company that aims to improve the lives of patients by accelerating the development and commercialization of medicines that matter. Roivant’s pipeline includes LISRAYA™ (brepocitinib), a potent small molecule inhibitor of JAK1 and TYK2 FDA-approved for the treatment of dermatomyositis in adult patients and also in late-stage development for the treatment of non-infectious uveitis, cutaneous sarcoidosis and lichen planopilaris; IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; and mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease. We advance our pipeline by creating nimble subsidiaries or “Vants” to develop and commercialize our medicines and technologies. For more information, visit .

Position: Executive Assistant

Candidates based in NY, NJ, or MA are strongly preferred.

Summary:

The successful candidate will provide high level administrative, communication and project management support in all facets of the daily business routine for team of senior leaders in the clinical and clinical trial/program group. The candidate will be flexible and open to unfamiliar assignments with excellent problem solving and critical thinking skills. Must handle multiple workstreams with adaptable and efficient prioritization. Should be highly organized and work well both collaboratively and autonomously. Candidate will be highly resourceful, composed, and empathetic. Must thrive in a fast-paced, start-up environment and work well under the pressure of multiple competing requests within tight timelines.

Key Duties and Responsibilities

Education and Experience

EssentialSkills andAbilities

Pulmovant provides equal employment opportunities to all employees and applicants for employment and prohibits discrimination and harassment of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by federal, state or local laws.

We will not accept unsolicited resumes nor outreach from agencies. Please do not send agency resumes to our website or Roivant Sciences and affiliated employees. Thanks!

Originally posted on Himalayas

Apply for this role Opens himalayas.app — the link as listed; we have not yet verified it is the employer's own page

Quick question · anonymous · one tap

Would you apply to this job?

Answer to see what other job seekers said.

Description review

57/100 HR standards 93/100 Title ↔ description 91/100 Fit to the official role
Read the marked-up listing →

Your turn · no account needed

Help the next applicant

You may know something about this listing that we cannot see from here. One tap. No account needed. Signed-in reports earn points once the evidence agrees with you.

I know what it pays

What you were offered, quoted in an interview, or paid in this role. A range is fine.

Sign in with Google to earn points for reports — 100 confirmed points buy a week of Early Access.

Where this listing came from

  1. 12 Oct 2026 Himalayas first sighting

Seen on 1 board over 0 days.